medigraphic.com
ISSN 1527-3172 (Electronic)

2010, Number 1

<< Back Next >>

MEDICC Review 2010; 12 (1)

Effectiveness and safety of tisuacryl in treating Dntin Hypersensitivity (DH)

Pérez MC, Guerra RM, Fernández M, Márquez D, Velazco G, Rodríguez J, Alemán E, García L, Suárez O, Rodríguez MC, Sañudo J

Language: English
References: 33
Page: 24-28
PDF size: 152.31 Kb.


ABSTRACT

Introduction Dentin hypersensitivity (DH) is a painful tooth condition affecting a large proportion of the world population. While DH is not a direct cause of tooth loss, it does cause discomfort and stress. DH treatment methods include desensitizers, such as fluoride compounds; polycyanoacrylate coating; low intensity laser therapy; and surgery as a last resort. In Cuba, a fluoride varnish, Profilac, is widely used with acceptable results. Tisuacryl, an N-butyl-2-cyanoacrylatebased tissue adhesive is licensed in Cuba as a medical device used for closing wounds and as a protective covering or dressing for oral tissues. Experimental use of Tisuacryl in DH treatment has begun recently with good results.
Objective Evaluate the effectiveness and safety of Tisuacryl in treating dentin hypersensitivity.
Methods An experimental, prospective, longitudinal, multicenter, non-controlled clinical investigation was conducted using the licensed medical device Tisuacryl. The study universe consisted of patients with DH symptoms who sought treatment at three dental clinics in Havana Province between May 2007 and February 2009. The sample consisted of 152 patients who met inclusion and diagnostic criteria for the study. DH was classified as severe, moderate, or mild. Remission of dentinal pain was the principal variable for evaluating effectiveness. Safety variables were mucosal irritation and burning sensation at the treatment site. Treatment was considered successful if DH was cured, defined as remission of pain and relief of discomfort (irritation or burning sensation) with no other adverse events by the final evaluation on day 6 after treatment initiation.
Results Tisuacryl treatment was successful in 96.7% of patients (81.5% with severe DH and 100% with mild to moderate DH). Mucosal irritation was observed in only 1 patient at first evaluation on day 2 but disappeared by the second evaluation. No other adverse events were reported.
Conclusions Tisuacryl was shown to be an effective, safe treatment of dentin hypersensitivity, especially moderate and mild cases.


REFERENCES

  1. Pérez Ruíz AO. Dolor bucodental. In: Bello Álvarez D, editor. El estomatólogo, su relación con el dolor y la sangre. 5th ed. Havana: Editorial Ciencias Médicas; 2008. p.192–209.

  2. Addy M. Dentine hypersensitivity: New perspectives on an old problem. Int Dent J. 2002;52(5 Suppl 1):S367–75.

  3. Hastings C. Dentinal hypersensitivity - dental hygiene and periodontal considerations. Int Dent J. 2002;52(5 Suppl 1):S385–93.

  4. Porto IC, Andrade AK, Montes MA. Diagnosis and treatment of dentinal hypersensitivity. J Oral Sci. 2009 Sep;51(3):323–32.

  5. Barroso M. Hiperestesia dentinaria. Rev de Ciencias Médicas de La Habana. 2008;14(1):171–5.

  6. MacCarthy D. Dentine hypersensitivity a review of literature. J Ir Dent Assoc. 2004 Spring;50(1):36–41.

  7. Zandim DL, Correa FO, Rossa JC, Sampaio JE. In vitro evaluation of the effect of natural orange juices on dentin morphology. Braz Oral Res. 2008 Apr-Jun;22(2):176–83.

  8. Romero IM, Escalona L, Acevedo AM. Frecuencia de hipersensibilidad dentinaria posterior al raspado y alisado radicular en un grupo de pacientes evaluados en el postgrado de periodoncia de la Facultad de Odontología. Acta Odontol Venez. 2008 Dec;46(3):284–8.

  9. Kielbassa AM. Hipersensibilidad dentinaria: Pasos simples para el diagnóstico y tratamiento diario. Int Dent J. 2002;52(5 Suppl 1):S394–6.

  10. Dowell P, Addy M, Dummer P. Dentine hypersensitivity: etiology, differential diagnosis and management. Br Dent J. 1985 Feb 9;158(3):92– 6.

  11. Arango GN, Latorre F. Comparación del injerto gingival libre y el injerto submucoso de tejido conectivo para el cubrimiento de recesiones marginales gingivales. Rev Fac Odontol Univ Antioquia. 2001 Jul-Dec;13(1):79–88.

  12. Gil FJ, Alpiste F, Pascual A, Figueroa Á. ¿Son los adhesivos dentinarios una opción válida para el tratamiento de la sensibilidad cervical dentinaria? RCOE. 2006 May-Jun;11(3):281–90.

  13. Herod EL. Cyanoacrylates in dentistry: a review of the literature. J Can Dent Assoc. 1990 Apr;56(4):331–4.

  14. Rosenthal MW. Historic review of the management of tooth hypersensitivity. Dent Clin North Am. 1990 Jul;34(3):403–27.

  15. David B, Barkhordar RA, Bhinda SV. Cyanoacrylate- a new treatment for hypersensitive dentin and cementum. J Am Dent Assoc. 1987 Apr;114(4):486–8.

  16. Kimura Y, Wilder-Smith P, Yonaga K, Matsumoto K. Treatment of dentine hypersensitivity by lasers: a review. J Clin Periodontol. 2000 Oct;27(10):715–21.

  17. Berástegui JE. Características clínicas de la permeabilidad dentinaria: sensibilidad dentinaria. Rev Facultad de Odontología de Barcelona. 2005;8(10):107–13.

  18. Fernández MI. Eficacia del Tisuacryl® versus Profilac en el tratamiento de la hiperestesia dentinaria [thesis]. Clínica XI Festival de la Juventud y los Estudiantes, Facultad de Ciencias Médicas Habana-Oeste; 2006.

  19. Tisuacryl® Adhesivo Tisular, Centro de Biomateriales, Universidad de la Habana. Certificado de Inscripción No. 79 MFI. Centro de Control Estatal de Equipos Médicos (CCEEM). Havana; October 1998.

  20. Guerra RM, Pérez MC, Roque R, Bomant E, González Y, Palenzuela T. Efectividad del adhesivo tisular Tisuacryl® en el cierre de heridas cutáneas. Rev Cubana Med Gen Integr. 2005;21(1):86–94.

  21. Pérez M, Fernández I, Márquez D, Guerra RM. Use of N-butyl-2 cyanoacrylate in oral surgery: biological and clinical evaluation. Artif Organs. 2000 Mar;24(3):241–3.

  22. Pérez MC, Cachimaille Y, Marrero MA, Guerra RM, Bomant E, Calzadilla OL, et al. Ensayo clínico fase III. Empleo del adhesivo tisular Tisuacryl® en el cierre de heridas del complejo maxilofacial. Revista Odontológica de los Andes. 2008;6(3):13–20.

  23. Barroso M, Alemán E, Pajón P. Efectividad del Tisuacryl en los traumatismos de la mucosa bucal e hiperestesia dentinaria. Rev Ciencias Médicas La Habana. 2008;14(2):200–8.

  24. Reglamento para la Evaluación y el Control Estatal de Equipos Médicos. Resolución Ministerial No. 184 del MINSAP. Aprobado: 2008.09.22. Gaceta Oficial (CU). 2008 Dec 22; 1424–36.

  25. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford: Blackwell Scientific Publications; 1987.

  26. Declaración Helsinki de la Asamblea Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. 59th World Medical Association General Assembly. Seoul, Korea, October 2008.

  27. Guía para la aplicación de las buenas prácticas clínicas en la ejecución de las investigaciones clínicas para la evaluación de equipos médicos. Centro de Control Estatal de Equipos Médicos. Havana: GE-5 MINSAP;1996.

  28. Cummins D. Dentin hypersensitivity: from diagnosis to a breakthrough therapy for everyday sensitivity relief. J Clin Dent. 2009;20(1):1–9.

  29. Pérez MC, Guerra RM. Acción analgésica del adhesivo tisular Tisuacryl en laceraciones de la mucosa bucal. BFMC. 2005;6(1):34–7.

  30. Barreras M, Barreras LM, Guerra RM. Eficacia del Tisuacryl en las intervenciones quirúrgicas periodontales. Rev CENIC Cienc Biol. 2006 Sep;37(3):143–6.

  31. Hernández S. Laser terapia en hiperestesia dentinal [homepage on the Internet]. Revista Ciencias; 2007 May [cited 2007 May 7]. Available from: http://www.revistaciencias.com/publicaciones/ EEZlVZVFEAjlDTFbxB.php

  32. Sarmiento ME, Hernández BP, Elicio FP, Arta AS. Láser y propusén en el tratamiento de la hiperestesia dentinal. Correo Científico Médico de Holguín. 2002;6(1):66–78.

  33. Pereira JC, Bonato AC, Figueiredo S, Tung Ming S. Hiperestesia dentinaria. Braz Dent J. 2002;13(2):2–7.




2020     |     www.medigraphic.com